Former hedge fund analyst at Bristol Capital for over 50 direct healthcare investments; Experienced biotech entrepreneur, Founder of Genesis, now Lion Biotech (NASDAQ:LBIO), Co-Founder of Intervene Immune. B.S. in Electrical Eng., Georgia Tech; M.S. in Biomedical Eng., UCLA.
Richard McKilligan, JD, MBA
Ex-Morgan, Lewis, & Bockius LLP, State Bars in CA and NY, CPA (inactive). JD from Cornell, MBA from Univ of Chicago, BS in Accounting from Univ of Illinois.
Avtar Dhillon, MD
Chairman & Co-founder
Chairman, Inovio Pharmaceuticals, Oncosec Medical, and Arch Therapeutics. Raised $200M in public markets over last 10 years. Former venture capitalist and family physician for over 10 years.
Anthony Maida, PhD, MBA
Director, Chair of Audit Committee
Senior Vice President, Clinical Research, Northwest Bio. MBA, MA in Toxicology, PhD in Immunology.
Brandon Zipp, PhD
Director of R&D, Scientific Co-founder
10 years research experience with glucosyltransferase enzymes. Developer of UGT biosynthesis platform. Ph.D., Biochem & Molecular Biology, Univ. of California Davis.
Senior Regulatory Advisor
Led regulatory team at Shire (NASDAQ:SHPG) for LIALDA, an approved drug for IBD. Former VP of Reg. Affairs at Abbvie (NYSE:ABBV).